Average Co-Inventor Count = 6.90
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (17 from 2,405 patents)
2. Merck Canada Inc. (9 from 40 patents)
3. Other (1 from 832,843 patents)
4. Celgene Corporation (1 from 549 patents)
19 patents:
1. 11168093 - Thienopyridine inhibitors of RIPK2
2. 9822107 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
3. 9775839 - 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
4. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
5. 9598405 - Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
6. 9586931 - Triazolyl derivatives as Syk inhibitors
7. 9487504 - Imidazolyl analogs as syk inhibitors
8. 9416111 - Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors
9. 9376418 - Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
10. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
11. 9290490 - Aminopyrimidines as Syk inhibitors
12. 9242984 - Pyrazolyl derivatives as Syk inhibitors
13. 9216173 - 2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
14. 9145391 - Bipyridylaminopyridines as Syk inhibitors
15. 9120785 - Pyridyl aminopyridines as Syk inhibitors